Clinical Trials Browser

Recruiting × Carcinoma, Medullary × 30 days × Clear all

Pheochromocytoma, Thyroid Neoplasms, Carcinoma, Medullary

NCT06444880 2026-06-04

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

Phase 2 Recruiting

40 enrolled

Sarcoma

Sarcoma, Carcinoma, Medullary

NCT07259304 2026-05-28

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Recruiting

250 enrolled

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Bone Neoplasms, Brain Neoplasms, Uterine Cervical Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Ovarian Neoplasms, Testicular Neoplasms, Colorectal Neoplasms, Central Nervous System Neoplasms, Carcinoma, Medullary

NCT06814496 2026-05-20

RABBIT

Phase 1/2 Recruiting

30 enrolled

CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

Clinical Trials

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

RABBIT